I don't think the shareholders who bought in at 17 or 18c will be in the red for much longer trythree although who knows? The vagaries of the stockmarket are what make it interesting and unpredictable, so if you believe in the company, its management and the path it's heading on don't get too caught up in the day to day price movements. If AHZ can pull off the twin accomplishments of beginning commercial production of CardioCel for the US market from its new manufacturing facility and eliciting a strong t-cell response in Phase I patients then I have fair value for this stock at around 45c.
The science nerds need to step up, page-8
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 312 | $15.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 626 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |